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AID Is Essential for Immunoglobulin V Gene
Conversion in a Cultured B Cell Line
disrupt AID: one with a xanthine-guanine phosphoribo-
syltransferase (gpt) and the other with a neomycin phos-
photransferase (neo) positive selection marker (Figure
Reuben S. Harris,1 Julian E. Sale,
Svend K. Petersen-Mahrt,
and Michael S. Neuberger1
Medical Research Council Laboratory of 1B). In the first round of targeting, three out of seven
mycophenolic acid-resistant clones were found byMolecular Biology
Hills Road, Cambridge CB2 2QH Southern blot to have targeted one of the endogenous
AID alleles. In the second round, two out of forty clonesUnited Kingdom
were targeted (Figure 1C). Northern blot analysis re-
vealed that the targeting of both AID alleles had indeed
ablated AID mRNA expression (Figure 1D).Summary
In order to ascertain whether the ablation of AID had
any effect on the IgV gene conversion in DT40 cells, weFollowing productive V gene rearrangement, the func-
tional immunoglobulin genes in the B lymphocytes of exploited the fact that constitutive IgV gene conversion
in DT40 can lead to the introduction of inactivating muta-man and mouse are subjected to two further types of
genetic modification. Class-switch recombination, a tions in the rearranged IgV genes and thereby generate
variants that have lost surface (s) IgM expression [6–8].region-specific but largely nonhomologous recombi-
nation process, leads to a change in constant region Therefore, we expanded the AID/ (and control) cells
for 1 month, stained them with FITC-conjugated anti-of the expressed antibody. Somatic hypermutation in-
troduces multiple single nucleotide substitutions in IgM, and used flow cytometry to purify the 0.5% sIgMlow/
fraction. We then PCR amplified and sequenced theand around the rearranged V gene segments and un-
derpins affinity maturation. However, in chicken and rearranged V gene from these cells. Strikingly, out of
89 sequences determined from the AID-deficient DT40rabbits (but not man or mouse), an additional mecha-
nism, gene conversion, is a major contributor to V cells (corresponding to 35,600 bp), not a single gene
conversion event was detected (Figure 2A). The onlygene diversification [1]. It has been demonstrated re-
cently that both switch recombination and hypermuta- changes observed were three single nucleotide substi-
tutions, which, given their low prevalence (105), aretion are ablated in mice and humans lacking AID, a
B cell-specific protein of unknown molecular activity likely attributable to PCR error. In contrast, the same
experiment performed on the parental DT40 population[2–4]. Here we show that disruption of AID in the DT40
chicken B cell lymphoma leads to a failure to perform yields V-inactivating gene conversion events in more than
one third of the IgV sequences (Figures 2A and 2B).immunoglobulin V gene conversion. Thus, AID is re-
quired for all three immunoglobulin gene modifica- This result strongly suggested that, in contrast to the
parental DT40 line, bona fide sIgM-loss variants wouldtion programs (gene conversion, hypermutation, and
switch recombination) and acts in the initiation or exe- not be obtainable readily from the AID-deficient deriva-
tives. This is indeed the case. A putative sIgMlow/ popu-cution of these processes rather than in bringing the
B cell to an appropriate stage of differentiation. lation was obtained in a single round of sorting of paren-
tal DT40 cells stained with FITC-conjugated anti-IgM;
following expansion, this sorted population was foundResults and Discussion
on reanalysis to be largely composed of true sIgM-loss
variants (Figure 2C). In contrast, such loss variants wereThe chicken DT40 cell line [5] is derived from a bursal cell
lymphoma and diversifies its immunoglobulin V genes not obtained in parallel experiments performed on the
AID-deficient clones whether the cells were sorted forconstitutively during culture by gene conversion [6, 7].
In order to ascertain whether V gene conversion was low expression of either sIgM (Figure 2C) or of sIg (data
not shown).dependent upon AID, we sought to disrupt both AID
alleles in DT40 cells. A cDNA clone corresponding to To confirm that the lack of IgV gene conversion in the
AID-deficient DT40 cells was indeed due to the lack ofpart of AID (Figure 1A) was obtained from DT40, using
AID expression, we established transfectants of AID/RT-PCR with primers based on consensus human and
DT40 that expressed a human (h) AID cDNA under CMVmouse AID sequences. This cDNA was used to probe
promoter control (Figure 2D). Fluctuation analyses per-a phage  chicken genomic DNA library and to design
formed on these AID/ [hAID] transfectants (as wellprimers for 3 RACE. A comparison of the resulting pre-
as on vector-only controls) revealed that the hAID haddicted AID coding regions and available database se-
indeed restored the ability of the AID-deficient DT40quences revealed over 90% identity between chicken
cells to generate sIgM-loss variants which could be puri-AID and that of man and rodents (Figure 1A). Southern
fied by sorting (Figures 2E and 2F).blot analysis with a variety of restriction enzymes indi-
The finding that AID is required for IgV gene conver-cated that the chicken AID probe identified a single
sion in an immortalized B cell line points to a closegene.
involvement of AID in the immunoglobulin gene diversifi-Two targeting constructs were generated in order to
cation process—rather than in, say, bringing the B cell
to a stage of differentiation where it can perform these1Correspondence: msn@mrc-lmb.cam.ac.uk (M.S.N.), rsharris@
mrc-lmb.cam.ac.uk (R.S.H.) processes. It also provides further strong support to the
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Figure 1. Disruption of AID in DT40
(A) Comparison of the deduced amino acid sequence of chicken AID with that of man, mouse, and rat. The boxed regions are the likely zinc
binding residues (inferred from homology with Apobec-1 and bacterial cytidine deaminase; see [2]), and the arrows indicate the locations of
the degenerate oligonucleotides (5-CGGAATTCTCNTGGAGYCCNTG and 5-CGGGATCCCCARCARTA; r  purine, y  pyrimidine, and n 
any of the four bases) used for PCR amplifying the initial AID cDNA fragment from DT40. The C-terminal portion of the DT40 AID sequence
was obtained by 3-RACE, whereas the N-terminal portion of the chicken AID protein sequence was obtained by combining sequence from
the phage  genomic chicken AID clone (below) and the EST database (RIKEN1_12J9R1). The AID sequences from other species are from
GI:11434250, GI:6753017, and GI:15624662.
(B) Strategy used to disrupt AID in DT40. The genomic restriction map was deduced from a phage  clone obtained from a 10-day-old White
Leghorn spleen library (Stratagene), with the exon locations approximated by hybridization and partial DNA sequencing; exon 1 was not
identified. Coding regions are in open boxes, with the 3-untranslated region in gray. B, BglII; H, HindIII; S, SacI. In the gpt targeting construct,
the 2 kb BglII fragment containing AID exon 2 was replaced with a BamHI fragment encoding gpt driven by a -actin promoter (this selective
marker was kind gift of S. Takeda, Japan). In the neo/tk targeting construct, a neo/tk expression cassette [14] replaces the region of AID
between the BglII site in intron 2 and codon position 115 in exon 3. The locations of the two probes used for Southern blot analysis are
shown. Both constructs were linearized by NotI digestion prior to electroportation (250V, 950 Fa; BioRad GenePulser II) into DT40 with cells
selected as described previously [8].
(C) Southern blot analysis confirming homologous recombination events at AID loci in DT40 transfectants. Genomic DNA was digested with
HindIII and subsequently hybridized with the 3 probe. The germline DNA gives rise to 8.0 and 0.9 kb bands, with the 8.0 kb band being
substituted following targeted integration by a 3 kb band (gpt construct) or 1.5 kb band (neo/tk tconstruct). Targeting with the neo/tk cassette
was identified initially using Southern blot analysis of SacI-digested genomic DNA and the 5 probe (data not shown).
(D) AID expression in targeted DT40 clones as judged by Northern blot hybridization using the partial chicken AID cDNA (cAID) probe described
above. RNA loading and quality was controlled by rehybridizing with an Ig C region probe; weak nonspecific hybridization with rRNA is also
shown.
proposal that IgV gene conversion and somatic hyper- common in the targeting of the initiating DNA lesion
[11, 12] as well as with more recent findings that themutation constitute different pathways of resolving a
common initiating DNA lesion [8–10]. Furthermore, tak- formation of switch-associated -H2AX nuclear foci is
dependent upon AID [13], it is likely that AID is involveding this evidence of an intimate involvement of AID with
all three immunoglobulin gene diversification processes in the formation of an initiating DNA lesion common to
switch recombination, hypermutation, and gene conver-together with earlier indications that somatic hypermu-
tation and class switch recombination share aspects in sion. The availability of a genetically tractable cell line
(E) Comparison of the prevalence of sIgMlow/ cells after 1 month of expansion of clones of AID/ and AID/ DT40 cells as well as in AID/
DT40 cells transfected with hAID (or vector alone). The median percentage of sIgMlow/ cells is shown in each case.
(F) Transfection of AID/ cells with a hAID expression construct allows the generation of bona fide sIgM-negative variants. Following expansion,
the sIgMlow/ subpopulation in pRH187 transfectants of AID/ DT40 was sorted, cultured, and reanalyzed for sIgM expression by flow cytometry.
The percentage of sIgMlow/ cells in this sorted, reanalyzed population is shown and compared to controls.
Figure 2. Lack of IgV Gene Diversification in AID-Deficient DT40
(A) Analysis of IgV sequences in sorted sIgMlow/ cells. After 1 month of clonal expansion, DNA was extracted from a subpopulation of AID-
deficient (and control) DT40 cells that were sorted by flow cytometry to constitute the 0.5% fraction staining most weakly with FITC-conjugated
anti-IgM (Bethyl Laboratories, Montgomery, TX). Pie charts depict the proportion of sequences from parental (30 sequences) or AID-deficient
(89 sequences) cells exhibiting gene conversions or point mutations (0, 1, or 2 events per sequence). Cell sorting and analysis of IgV
sequences was performed as previously described [8].
(B) The gene conversion and point mutation events are shown in the sequence alignments with the IgV pseudogene donors identified as
previously [8]. An asterisk indicates a nucleotide deletion.
(C) AID-deficient DT40 cells do not yield a bona fide sIgM-negative population. The sIgMlow/ subpopulation in AID-deficient and control DT40
cells that had been expanded for 1 month was purified by flow cytometry (taking the dullest 0.5% of live cells), cultured for 7 days, and
reanalyzed for sIgM expression by flow cytometry. The percentage of sIgMlow/ cells in the pre- and postsort populations is indicated.
(D) Human AID (hAID) mRNA is detectable by Northern blot analysis of AID-deficient DT40 cells transfected with pRH187, a pIRESbleo
(Clontech) derivative expressing a hAID cDNA. Transfectants were selected in medium containing 50 g/ml phleomycin (Sigma), and the blot
was controlled as in Figure 1D.
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regions evidenced through Cre-loxP-mediated gene targeting.model in which AID activity can be assayed should prove
Cell 73, 1155–1164.useful in delineating the molecular role of AID in these
processes.
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